Organigram Announces Appointment of Karina Gehring to Board of Directors
19 January 2024 - 10:00PM
Business Wire
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX:
OGI) (NASDAQ: OGI), announced the appointment of Karina Gehring to
the Organigram Board of Directors at the Company’s annual general
and special meeting held on January 18, 2024.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240119151071/en/
Karina Gehring (Photo: Business Wire)
“We are thrilled to welcome Karina to our Board of Directors.
Her extensive expertise in marketing and brand management combined
with her ongoing experience with BAT will be a tremendous asset to
our Board,” said Peter Amirault, Board Chair, Organigram.
Karina is one of two directors (including Simon Ashton)
designated by BT DE Investments Inc., a wholly owned subsidiary of
British American Tobacco plc (“BAT”), as nominees to the Company’s
Board. Bringing over 25 years of experience in marketing and trade
at BAT, Mrs. Gehring is a seasoned executive proficient in
commercial delivery, brand management, strategy, consumer insights
and key account management. Leading diverse teams, she has played a
pivotal role in transformative initiatives across Europe and
Canada. Mrs. Gehring has successfully executed full portfolio brand
repositioning, deepened BAT’s consumer understanding to foster
connections beyond surface insights and introduced innovative key
account management programs.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and
TSX listed company whose wholly owned subsidiaries include
Organigram Inc. a licensed producer of cannabis, cannabis-derived
products and cannabis infused edibles in Canada.
Organigram is focused on producing high-quality cannabis for
patients and adult recreational consumers, as well as developing
international business partnerships to extend the Company's global
footprint. Organigram has also developed and acquired a portfolio
of legal adult-use recreational cannabis brands, including Edison,
Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour,
Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates
facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec,
with a dedicated edibles manufacturing facility in Winnipeg,
Manitoba. The Company is regulated by the Cannabis Act and the
Cannabis Regulations (Canada).
Forward-Looking Information
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include c
and factors and risks as disclosed in the Circular, and the
Company’s most recent annual information form, management’s
discussion and analysis and other Company documents filed from time
to time on SEDAR+ (see www.sedarplus.ca) and filed or furnished to
the Securities and Exchange Commission on EDGAR (see www.sec.gov).
Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date of this
press release. Although the Company believes that the assumptions
and factors used in preparing the forward-looking information in
this news release are reasonable, undue reliance should not be
placed on such information and no assurance can be given that such
events will occur in the disclosed time frames or at all. The
forward-looking information included in this news release are made
as of the date of this news release and the Company disclaims any
intention or obligation, except to the extent required by law, to
update or revise any forward-looking information, whether as a
result of new information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240119151071/en/
For Investor Relations enquiries: Max Schwartz, Director
of Investor Relations investors@organigram.ca
For Media enquiries: Megan McCrae, Senior Vice President
– Marketing and Communications megan.mccrae@organigram.ca
Organigram (NASDAQ:OGI)
Historical Stock Chart
From May 2024 to Jun 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Jun 2023 to Jun 2024